Industry Research Reports

Home > Reports > Service & Software > Post-Translational Modification Proteomics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Post-Translational Modification Proteomics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-17

Pages: 207 Pages

Report ld: 6977546

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Post-Translational Modification Proteomics Service Market Size(US$)

CAGR 2026-2032

10.3%

Market Size,2032

USD 1,485

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 827 million

Market Forecast in 2032(Value)

US$ 1,485 million

CAGR

10.3%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Post-Translational Modification Proteomics Service was estimated to be worth US$ 768 million in 2025 and is projected to reach US$ 1485 million, growing at a CAGR of 10.3% from 2026 to 2032.

Post-Translational Modification Proteomics Service (PTM Proteomics Service) refers to specialized research services that utilize advanced proteomics technologies to systematically identify, quantify, localize, and interpret chemical modifications occurring on proteins after translation. This service focuses on functional regulation at the protein level and provides insights into cellular signaling pathways, disease mechanisms, therapeutic responses, and biological regulation processes.

Major categories of PTM proteomics services include phosphoproteomics, glycoproteomics, ubiquitinomics, acetylproteomics, methylproteomics, succinylproteomics, oxidation proteomics, and other modification-specific analyses. These services typically integrate high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS), 4D proteomics, data-independent acquisition (DIA), isotope labeling quantification technologies such as TMT/iTRAQ, modification peptide enrichment strategies, and advanced bioinformatics platforms. The workflow covers sample preparation, modified peptide enrichment, modification site identification, differential modification analysis, pathway interpretation, and biological network analysis.

Unlike conventional proteomics, which primarily focuses on protein abundance changes, PTM proteomics provides deeper insights into functional protein regulation. It represents a critical molecular layer connecting genetic information with cellular phenotypes. Today, PTM proteomics services are widely applied in innovative drug discovery, oncology research, immunology, neuroscience, metabolic disease studies, and precision medicine, supporting target identification, biomarker discovery, and mechanism-of-disease investigations.

The PTM Proteomics Service industry mainly adopts a technology-driven CRO business model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities. Service providers establish high-end mass spectrometry facilities, including Orbitrap and timsTOF-based platforms, together with automated sample preparation systems, liquid chromatography separation workflows, PTM enrichment technologies, and computational analysis pipelines. These platforms provide customized research solutions for pharmaceutical companies, biotechnology firms, academic institutions, and healthcare research organizations.

The typical workflow includes experimental design, sample quality control, protein extraction, enzymatic digestion, PTM enrichment, LC-MS/MS analysis, database searching, modification site identification, statistical modeling, pathway analysis, and final scientific reporting.

The upstream value chain includes mass spectrometry manufacturers, chromatography suppliers, biochemical reagent companies, antibody and modified peptide suppliers, laboratory consumable providers, and bioinformatics software companies. The midstream consists of specialized proteomics CRO providers, multi-omics service companies, and life science technology platforms. Downstream users include pharmaceutical companies, biotechnology firms, research institutes, hospitals, disease research centers, and agricultural biotechnology organizations.

PTM Proteomics Service is a high-value-added life science service segment with attractive profitability. Standardized PTM analysis projects generally achieve gross margins of approximately 35%-55%. Advanced services such as large-scale phosphoproteomics, ubiquitinomics, clinical PTM profiling, and drug mechanism studies typically generate gross margins of around 50%-70% due to high equipment investment, workflow complexity, and specialized expertise requirements. Companies with proprietary analytical algorithms, databases, automated platforms, and pharmaceutical partnerships may achieve margins of 60%-75%.

PTM Proteomics Service is becoming a strategically important growth area in life science research and innovative drug development. As pharmaceutical research moves beyond gene expression toward functional protein regulation, demand for dynamic protein modification profiling continues to increase. PTM analysis provides critical functional information on signaling networks, protein degradation mechanisms, immune regulation, and therapeutic pathways that cannot be fully captured by genomics or transcriptomics alone. It has broad applications in precision oncology, immunotherapy, targeted therapies, and complex disease research. Advances in mass spectrometry, laboratory automation, AI-driven data interpretation, and multi-omics integration will continue to accelerate market expansion.

The PTM Proteomics Service industry faces challenges including complex experimental workflows, high analytical costs, sophisticated data interpretation requirements, and limited standardization. Different PTM types exhibit unique chemical characteristics and abundance levels, requiring specialized enrichment strategies and analytical methods. In addition, market growth may be affected by biotechnology funding cycles, drug development timelines, and research budget fluctuations. Companies need to continuously improve automation, computational capabilities, and standardized workflows to maintain sustainable competitiveness.

Future demand for PTM Proteomics Services will increasingly focus on high-throughput analysis, clinical translation, multi-omics integration, and intelligent data interpretation. Pharmaceutical companies will increasingly adopt PTM proteomics for target validation, mechanism-of-action studies, and companion diagnostic development to improve R&D efficiency. Biotechnology companies will rely on specialized outsourcing services to reduce infrastructure investment and accelerate innovation pipelines. Research institutions and healthcare organizations will expand applications in oncology, immune disorders, neurological diseases, and metabolic research. As precision medicine and data-driven biology continue to advance, PTM proteomics providers with advanced mass spectrometry platforms, comprehensive databases, and integrated analytical capabilities will achieve stronger positions in the global market.

This report provides a comprehensive view of the global market for Post-Translational Modification Proteomics Service, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Post-Translational Modification Proteomics Service market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Post-Translational Modification Proteomics Service.

MARKET SEGMENTATION

By Company

PTM BIO
Cell Signaling Technology (CST)
APTBIO
BGI Genomics
OmicScouts (Momentum Biotechnologies)
Biodesix
Shanghai OE Biotech
Crown Bioscience
Shanghai Bioprofile
Creative Proteomics
Inotiv
MtoZ-Biolabs
CellCarta
Biognosys
MS Bioworks
Charles River Laboratories
Metware Biotechnology
Novogene
Evotec
RxCelerate
Shanghai Majorbio Bio-Pharm
Lc-Bio Technologies
CD Genomics
Discovery Life Sciences
Applied Biomics
VProteomics
Allumiqs
Westlake Omics
CDI Labs
Proteome Sciences
Sapient Bioanalytics
Proteomics International
Cosmos Wisdom
MRM Proteomics
Sinotech Genomics
Precision Biomarker Laboratories (PBL)

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Phosphorylation
Acetylation
Ubiquitination
Methylation
Glycosylation
Lactylation
Redox
Palmitoylation
Others

Segment by Application

Clinical Diagnostics
Drug Discovery
Others

Segment by Category

Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others

Segment by Division

Oncology
Cardiovascular
Agriculture
Neuroscience
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Post-Translational Modification Proteomics Service companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Post-Translational Modification Proteomics Service revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Post-Translational Modification Proteomics Service revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Post-Translational Modification Proteomics Service Product Introduction

1.2 Global Post-Translational Modification Proteomics Service Market Size Forecast (2021–2032)

1.3 Post-Translational Modification Proteomics Service Market Trends & Drivers

1.3.1 Post-Translational Modification Proteomics Service Industry Trends

1.3.2 Post-Translational Modification Proteomics Service Market Drivers & Opportunities

1.3.3 Post-Translational Modification Proteomics Service Market Challenges

1.3.4 Post-Translational Modification Proteomics Service Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Post-Translational Modification Proteomics Service Players Revenue Ranking (2025)

2.2 Global Post-Translational Modification Proteomics Service Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Post-Translational Modification Proteomics Service Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Post-Translational Modification Proteomics Service

2.6 Post-Translational Modification Proteomics Service Market Competitive Analysis

2.6.1 Post-Translational Modification Proteomics Service Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Post-Translational Modification Proteomics Service Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Post-Translational Modification Proteomics Service revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Post-Translational Modification Proteomics Service Market Classification

3.1 Introduction by Type

3.1.1 Phosphorylation

3.1.2 Acetylation

3.1.3 Ubiquitination

3.1.4 Methylation

3.1.5 Glycosylation

3.1.6 Lactylation

3.1.7 Redox

3.1.8 Palmitoylation

3.1.9 Others

3.1.10 Global Post-Translational Modification Proteomics Service Sales Value by Type

3.1.10.1 Global Post-Translational Modification Proteomics Service Sales Value by Type (2021 vs 2025 vs 2032)

3.1.10.2 Global Post-Translational Modification Proteomics Service Sales Value, by Type (2021–2032)

3.1.10.3 Global Post-Translational Modification Proteomics Service Sales Value, by Type (%), 2021–2032

3.2 Introduction by End User

3.2.1 Universities and Research Institutes

3.2.2 Hospitals

3.2.3 Pharmaceutical Companies

3.2.4 Others

3.2.5 Global Post-Translational Modification Proteomics Service Sales Value by End User

3.2.5.1 Global Post-Translational Modification Proteomics Service Sales Value by End User (2021 vs 2025 vs 2032)

3.2.5.2 Global Post-Translational Modification Proteomics Service Sales Value, by End User (2021–2032)

3.2.5.3 Global Post-Translational Modification Proteomics Service Sales Value, by End User (%), 2021–2032

3.3 Introduction by Research Areas

3.3.1 Oncology

3.3.2 Cardiovascular

3.3.3 Agriculture

3.3.4 Neuroscience

3.3.5 Other

3.3.6 Global Post-Translational Modification Proteomics Service Sales Value by Research Areas

3.3.6.1 Global Post-Translational Modification Proteomics Service Sales Value by Research Areas (2021 vs 2025 vs 2032)

3.3.6.2 Global Post-Translational Modification Proteomics Service Sales Value, by Research Areas (2021–2032)

3.3.6.3 Global Post-Translational Modification Proteomics Service Sales Value, by Research Areas (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Clinical Diagnostics

4.1.2 Drug Discovery

4.1.3 Others

4.2 Global Post-Translational Modification Proteomics Service Sales Value by Application

4.2.1 Global Post-Translational Modification Proteomics Service Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Post-Translational Modification Proteomics Service Sales Value by Application (2021–2032)

4.2.3 Global Post-Translational Modification Proteomics Service Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Post-Translational Modification Proteomics Service Sales Value by Region

5.1.1 Global Post-Translational Modification Proteomics Service Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Post-Translational Modification Proteomics Service Sales Value by Region (2021–2026)

5.1.3 Global Post-Translational Modification Proteomics Service Sales Value by Region (2027–2032)

5.1.4 Global Post-Translational Modification Proteomics Service Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Post-Translational Modification Proteomics Service Sales Value, 2021–2032

5.2.2 North America Post-Translational Modification Proteomics Service Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Post-Translational Modification Proteomics Service Sales Value, 2021–2032

5.3.2 Europe Post-Translational Modification Proteomics Service Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Post-Translational Modification Proteomics Service Sales Value, 2021–2032

5.4.2 Asia Pacific Post-Translational Modification Proteomics Service Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Post-Translational Modification Proteomics Service Sales Value, 2021–2032

5.5.2 South America Post-Translational Modification Proteomics Service Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Post-Translational Modification Proteomics Service Sales Value, 2021–2032

5.6.2 Middle East & Africa Post-Translational Modification Proteomics Service Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Post-Translational Modification Proteomics Service Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Post-Translational Modification Proteomics Service Sales Value, 2021–2032

6.3 United States

6.3.1 United States Post-Translational Modification Proteomics Service Sales Value, 2021–2032

6.3.2 United States Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Post-Translational Modification Proteomics Service Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Post-Translational Modification Proteomics Service Sales Value, 2021–2032

6.4.2 Europe Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Post-Translational Modification Proteomics Service Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Post-Translational Modification Proteomics Service Sales Value, 2021–2032

6.5.2 China Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.5.3 China Post-Translational Modification Proteomics Service Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Post-Translational Modification Proteomics Service Sales Value, 2021–2032

6.6.2 Japan Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Post-Translational Modification Proteomics Service Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Post-Translational Modification Proteomics Service Sales Value, 2021–2032

6.7.2 South Korea Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Post-Translational Modification Proteomics Service Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Post-Translational Modification Proteomics Service Sales Value, 2021–2032

6.8.2 Southeast Asia Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Post-Translational Modification Proteomics Service Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Post-Translational Modification Proteomics Service Sales Value, 2021–2032

6.9.2 India Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

6.9.3 India Post-Translational Modification Proteomics Service Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 PTM BIO

7.1.1 PTM BIO Profile

7.1.2 PTM BIO Main Business

7.1.3 PTM BIO Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.1.4 PTM BIO Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.1.5 PTM BIO Recent Developments

7.2 Cell Signaling Technology (CST)

7.2.1 Cell Signaling Technology (CST) Profile

7.2.2 Cell Signaling Technology (CST) Main Business

7.2.3 Cell Signaling Technology (CST) Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.2.4 Cell Signaling Technology (CST) Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.2.5 Cell Signaling Technology (CST) Recent Developments

7.3 APTBIO

7.3.1 APTBIO Profile

7.3.2 APTBIO Main Business

7.3.3 APTBIO Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.3.4 APTBIO Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.3.5 APTBIO Recent Developments

7.4 BGI Genomics

7.4.1 BGI Genomics Profile

7.4.2 BGI Genomics Main Business

7.4.3 BGI Genomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.4.4 BGI Genomics Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.4.5 BGI Genomics Recent Developments

7.5 OmicScouts (Momentum Biotechnologies)

7.5.1 OmicScouts (Momentum Biotechnologies) Profile

7.5.2 OmicScouts (Momentum Biotechnologies) Main Business

7.5.3 OmicScouts (Momentum Biotechnologies) Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.5.4 OmicScouts (Momentum Biotechnologies) Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.5.5 OmicScouts (Momentum Biotechnologies) Recent Developments

7.6 Biodesix

7.6.1 Biodesix Profile

7.6.2 Biodesix Main Business

7.6.3 Biodesix Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.6.4 Biodesix Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.6.5 Biodesix Recent Developments

7.7 Shanghai OE Biotech

7.7.1 Shanghai OE Biotech Profile

7.7.2 Shanghai OE Biotech Main Business

7.7.3 Shanghai OE Biotech Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.7.4 Shanghai OE Biotech Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.7.5 Shanghai OE Biotech Recent Developments

7.8 Crown Bioscience

7.8.1 Crown Bioscience Profile

7.8.2 Crown Bioscience Main Business

7.8.3 Crown Bioscience Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.8.4 Crown Bioscience Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.8.5 Crown Bioscience Recent Developments

7.9 Shanghai Bioprofile

7.9.1 Shanghai Bioprofile Profile

7.9.2 Shanghai Bioprofile Main Business

7.9.3 Shanghai Bioprofile Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.9.4 Shanghai Bioprofile Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.9.5 Shanghai Bioprofile Recent Developments

7.10 Creative Proteomics

7.10.1 Creative Proteomics Profile

7.10.2 Creative Proteomics Main Business

7.10.3 Creative Proteomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.10.4 Creative Proteomics Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.10.5 Creative Proteomics Recent Developments

7.11 Inotiv

7.11.1 Inotiv Profile

7.11.2 Inotiv Main Business

7.11.3 Inotiv Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.11.4 Inotiv Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.11.5 Inotiv Recent Developments

7.12 MtoZ-Biolabs

7.12.1 MtoZ-Biolabs Profile

7.12.2 MtoZ-Biolabs Main Business

7.12.3 MtoZ-Biolabs Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.12.4 MtoZ-Biolabs Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.12.5 MtoZ-Biolabs Recent Developments

7.13 CellCarta

7.13.1 CellCarta Profile

7.13.2 CellCarta Main Business

7.13.3 CellCarta Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.13.4 CellCarta Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.13.5 CellCarta Recent Developments

7.14 Biognosys

7.14.1 Biognosys Profile

7.14.2 Biognosys Main Business

7.14.3 Biognosys Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.14.4 Biognosys Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.14.5 Biognosys Recent Developments

7.15 MS Bioworks

7.15.1 MS Bioworks Profile

7.15.2 MS Bioworks Main Business

7.15.3 MS Bioworks Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.15.4 MS Bioworks Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.15.5 MS Bioworks Recent Developments

7.16 Charles River Laboratories

7.16.1 Charles River Laboratories Profile

7.16.2 Charles River Laboratories Main Business

7.16.3 Charles River Laboratories Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.16.4 Charles River Laboratories Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.16.5 Charles River Laboratories Recent Developments

7.17 Metware Biotechnology

7.17.1 Metware Biotechnology Profile

7.17.2 Metware Biotechnology Main Business

7.17.3 Metware Biotechnology Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.17.4 Metware Biotechnology Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.17.5 Metware Biotechnology Recent Developments

7.18 Novogene

7.18.1 Novogene Profile

7.18.2 Novogene Main Business

7.18.3 Novogene Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.18.4 Novogene Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.18.5 Novogene Recent Developments

7.19 Evotec

7.19.1 Evotec Profile

7.19.2 Evotec Main Business

7.19.3 Evotec Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.19.4 Evotec Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.19.5 Evotec Recent Developments

7.20 RxCelerate

7.20.1 RxCelerate Profile

7.20.2 RxCelerate Main Business

7.20.3 RxCelerate Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.20.4 RxCelerate Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.20.5 RxCelerate Recent Developments

7.21 Shanghai Majorbio Bio-Pharm

7.21.1 Shanghai Majorbio Bio-Pharm Profile

7.21.2 Shanghai Majorbio Bio-Pharm Main Business

7.21.3 Shanghai Majorbio Bio-Pharm Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.21.4 Shanghai Majorbio Bio-Pharm Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.21.5 Shanghai Majorbio Bio-Pharm Recent Developments

7.22 Lc-Bio Technologies

7.22.1 Lc-Bio Technologies Profile

7.22.2 Lc-Bio Technologies Main Business

7.22.3 Lc-Bio Technologies Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.22.4 Lc-Bio Technologies Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.22.5 Lc-Bio Technologies Recent Developments

7.23 CD Genomics

7.23.1 CD Genomics Profile

7.23.2 CD Genomics Main Business

7.23.3 CD Genomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.23.4 CD Genomics Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.23.5 CD Genomics Recent Developments

7.24 Discovery Life Sciences

7.24.1 Discovery Life Sciences Profile

7.24.2 Discovery Life Sciences Main Business

7.24.3 Discovery Life Sciences Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.24.4 Discovery Life Sciences Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.24.5 Discovery Life Sciences Recent Developments

7.25 Applied Biomics

7.25.1 Applied Biomics Profile

7.25.2 Applied Biomics Main Business

7.25.3 Applied Biomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.25.4 Applied Biomics Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.25.5 Applied Biomics Recent Developments

7.26 VProteomics

7.26.1 VProteomics Profile

7.26.2 VProteomics Main Business

7.26.3 VProteomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.26.4 VProteomics Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.26.5 VProteomics Recent Developments

7.27 Allumiqs

7.27.1 Allumiqs Profile

7.27.2 Allumiqs Main Business

7.27.3 Allumiqs Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.27.4 Allumiqs Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.27.5 Allumiqs Recent Developments

7.28 Westlake Omics

7.28.1 Westlake Omics Profile

7.28.2 Westlake Omics Main Business

7.28.3 Westlake Omics Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.28.4 Westlake Omics Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.28.5 Westlake Omics Recent Developments

7.29 CDI Labs

7.29.1 CDI Labs Profile

7.29.2 CDI Labs Main Business

7.29.3 CDI Labs Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.29.4 CDI Labs Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.29.5 CDI Labs Recent Developments

7.30 Proteome Sciences

7.30.1 Proteome Sciences Profile

7.30.2 Proteome Sciences Main Business

7.30.3 Proteome Sciences Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.30.4 Proteome Sciences Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.30.5 Proteome Sciences Recent Developments

7.31 Sapient Bioanalytics

7.31.1 Sapient Bioanalytics Profile

7.31.2 Sapient Bioanalytics Main Business

7.31.3 Sapient Bioanalytics Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.31.4 Sapient Bioanalytics Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.31.5 Sapient Bioanalytics Recent Developments

7.32 Proteomics International

7.32.1 Proteomics International Profile

7.32.2 Proteomics International Main Business

7.32.3 Proteomics International Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.32.4 Proteomics International Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.32.5 Proteomics International Recent Developments

7.33 Cosmos Wisdom

7.33.1 Cosmos Wisdom Profile

7.33.2 Cosmos Wisdom Main Business

7.33.3 Cosmos Wisdom Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.33.4 Cosmos Wisdom Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.33.5 Cosmos Wisdom Recent Developments

7.34 MRM Proteomics

7.34.1 MRM Proteomics Profile

7.34.2 MRM Proteomics Main Business

7.34.3 MRM Proteomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.34.4 MRM Proteomics Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.34.5 MRM Proteomics Recent Developments

7.35 Sinotech Genomics

7.35.1 Sinotech Genomics Profile

7.35.2 Sinotech Genomics Main Business

7.35.3 Sinotech Genomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.35.4 Sinotech Genomics Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.35.5 Sinotech Genomics Recent Developments

7.36 Precision Biomarker Laboratories (PBL)

7.36.1 Precision Biomarker Laboratories (PBL) Profile

7.36.2 Precision Biomarker Laboratories (PBL) Main Business

7.36.3 Precision Biomarker Laboratories (PBL) Post-Translational Modification Proteomics Service Products, Services, and Solutions

7.36.4 Precision Biomarker Laboratories (PBL) Post-Translational Modification Proteomics Service Revenue (US$ Million), 2021–2026

7.36.5 Precision Biomarker Laboratories (PBL) Recent Developments

8 Industry Chain Analysis

8.1 Post-Translational Modification Proteomics Service Value Chain

8.2 Post-Translational Modification Proteomics Service Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Post-Translational Modification Proteomics Service Sales Model

8.5.2 Sales Channels

8.5.3 Post-Translational Modification Proteomics Service Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Post-Translational Modification Proteomics Service Market Trends

Table 2. Post-Translational Modification Proteomics Service Market Drivers & Opportunities

Table 3. Post-Translational Modification Proteomics Service Market Challenges

Table 4. Post-Translational Modification Proteomics Service Market Restraints

Table 5. Global Post-Translational Modification Proteomics Service Revenue by Company (US$ Million), 2021–2026

Table 6. Global Post-Translational Modification Proteomics Service Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Post-Translational Modification Proteomics Service Product Type

Table 9. Key Companies General Availability (GA) Timeline for Post-Translational Modification Proteomics Service

Table 10. Global Post-Translational Modification Proteomics Service Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Post-Translational Modification Proteomics Service revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Post-Translational Modification Proteomics Service Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Post-Translational Modification Proteomics Service Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Post-Translational Modification Proteomics Service Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Post-Translational Modification Proteomics Service Sales Market Share in Value by Type (2021–2026)

Table 17. Global Post-Translational Modification Proteomics Service Sales Market Share in Value by Type (2027–2032)

Table 18. Global Post-Translational Modification Proteomics Service Sales Value by End User: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Post-Translational Modification Proteomics Service Sales Value by End User (US$ Million), 2021–2026

Table 20. Global Post-Translational Modification Proteomics Service Sales Value by End User (US$ Million), 2027–2032

Table 21. Global Post-Translational Modification Proteomics Service Sales Market Share in Value by End User (2021–2026)

Table 22. Global Post-Translational Modification Proteomics Service Sales Market Share in Value by End User (2027–2032)

Table 23. Global Post-Translational Modification Proteomics Service Sales Value by Research Areas: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global Post-Translational Modification Proteomics Service Sales Value by Research Areas (US$ Million), 2021–2026

Table 25. Global Post-Translational Modification Proteomics Service Sales Value by Research Areas (US$ Million), 2027–2032

Table 26. Global Post-Translational Modification Proteomics Service Sales Market Share in Value by Research Areas (2021–2026)

Table 27. Global Post-Translational Modification Proteomics Service Sales Market Share in Value by Research Areas (2027–2032)

Table 28. Global Post-Translational Modification Proteomics Service Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Post-Translational Modification Proteomics Service Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Post-Translational Modification Proteomics Service Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Post-Translational Modification Proteomics Service Sales Market Share in Value by Application (2021–2026)

Table 32. Global Post-Translational Modification Proteomics Service Sales Market Share in Value by Application (2027–2032)

Table 33. Global Post-Translational Modification Proteomics Service Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 34. Global Post-Translational Modification Proteomics Service Sales Value by Region (US$ Million), 2021–2026

Table 35. Global Post-Translational Modification Proteomics Service Sales Value by Region (US$ Million), 2027–2032

Table 36. Global Post-Translational Modification Proteomics Service Sales Value by Region (%), 2021–2026

Table 37. Global Post-Translational Modification Proteomics Service Sales Value by Region (%), 2027–2032

Table 38. Key Countries/Regions Post-Translational Modification Proteomics Service Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 39. Key Countries/Regions Post-Translational Modification Proteomics Service Sales Value, (US$ Million), 2021–2026

Table 40. Key Countries/Regions Post-Translational Modification Proteomics Service Sales Value, (US$ Million), 2027–2032

Table 41. PTM BIO Basic Information List

Table 42. PTM BIO Description and Business Overview

Table 43. PTM BIO Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of PTM BIO (2021–2026)

Table 45. PTM BIO Recent Developments

Table 46. Cell Signaling Technology (CST) Basic Information List

Table 47. Cell Signaling Technology (CST) Description and Business Overview

Table 48. Cell Signaling Technology (CST) Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Cell Signaling Technology (CST) (2021–2026)

Table 50. Cell Signaling Technology (CST) Recent Developments

Table 51. APTBIO Basic Information List

Table 52. APTBIO Description and Business Overview

Table 53. APTBIO Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of APTBIO (2021–2026)

Table 55. APTBIO Recent Developments

Table 56. BGI Genomics Basic Information List

Table 57. BGI Genomics Description and Business Overview

Table 58. BGI Genomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of BGI Genomics (2021–2026)

Table 60. BGI Genomics Recent Developments

Table 61. OmicScouts (Momentum Biotechnologies) Basic Information List

Table 62. OmicScouts (Momentum Biotechnologies) Description and Business Overview

Table 63. OmicScouts (Momentum Biotechnologies) Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of OmicScouts (Momentum Biotechnologies) (2021–2026)

Table 65. OmicScouts (Momentum Biotechnologies) Recent Developments

Table 66. Biodesix Basic Information List

Table 67. Biodesix Description and Business Overview

Table 68. Biodesix Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Biodesix (2021–2026)

Table 70. Biodesix Recent Developments

Table 71. Shanghai OE Biotech Basic Information List

Table 72. Shanghai OE Biotech Description and Business Overview

Table 73. Shanghai OE Biotech Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Shanghai OE Biotech (2021–2026)

Table 75. Shanghai OE Biotech Recent Developments

Table 76. Crown Bioscience Basic Information List

Table 77. Crown Bioscience Description and Business Overview

Table 78. Crown Bioscience Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Crown Bioscience (2021–2026)

Table 80. Crown Bioscience Recent Developments

Table 81. Shanghai Bioprofile Basic Information List

Table 82. Shanghai Bioprofile Description and Business Overview

Table 83. Shanghai Bioprofile Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Shanghai Bioprofile (2021–2026)

Table 85. Shanghai Bioprofile Recent Developments

Table 86. Creative Proteomics Basic Information List

Table 87. Creative Proteomics Description and Business Overview

Table 88. Creative Proteomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Creative Proteomics (2021–2026)

Table 90. Creative Proteomics Recent Developments

Table 91. Inotiv Basic Information List

Table 92. Inotiv Description and Business Overview

Table 93. Inotiv Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Inotiv (2021–2026)

Table 95. Inotiv Recent Developments

Table 96. MtoZ-Biolabs Basic Information List

Table 97. MtoZ-Biolabs Description and Business Overview

Table 98. MtoZ-Biolabs Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of MtoZ-Biolabs (2021–2026)

Table 100. MtoZ-Biolabs Recent Developments

Table 101. CellCarta Basic Information List

Table 102. CellCarta Description and Business Overview

Table 103. CellCarta Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of CellCarta (2021–2026)

Table 105. CellCarta Recent Developments

Table 106. Biognosys Basic Information List

Table 107. Biognosys Description and Business Overview

Table 108. Biognosys Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Biognosys (2021–2026)

Table 110. Biognosys Recent Developments

Table 111. MS Bioworks Basic Information List

Table 112. MS Bioworks Description and Business Overview

Table 113. MS Bioworks Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of MS Bioworks (2021–2026)

Table 115. MS Bioworks Recent Developments

Table 116. Charles River Laboratories Basic Information List

Table 117. Charles River Laboratories Description and Business Overview

Table 118. Charles River Laboratories Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Charles River Laboratories (2021–2026)

Table 120. Charles River Laboratories Recent Developments

Table 121. Metware Biotechnology Basic Information List

Table 122. Metware Biotechnology Description and Business Overview

Table 123. Metware Biotechnology Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 124. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Metware Biotechnology (2021–2026)

Table 125. Metware Biotechnology Recent Developments

Table 126. Novogene Basic Information List

Table 127. Novogene Description and Business Overview

Table 128. Novogene Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 129. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Novogene (2021–2026)

Table 130. Novogene Recent Developments

Table 131. Evotec Basic Information List

Table 132. Evotec Description and Business Overview

Table 133. Evotec Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 134. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Evotec (2021–2026)

Table 135. Evotec Recent Developments

Table 136. RxCelerate Basic Information List

Table 137. RxCelerate Description and Business Overview

Table 138. RxCelerate Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 139. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of RxCelerate (2021–2026)

Table 140. RxCelerate Recent Developments

Table 141. Shanghai Majorbio Bio-Pharm Basic Information List

Table 142. Shanghai Majorbio Bio-Pharm Description and Business Overview

Table 143. Shanghai Majorbio Bio-Pharm Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 144. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Shanghai Majorbio Bio-Pharm (2021–2026)

Table 145. Shanghai Majorbio Bio-Pharm Recent Developments

Table 146. Lc-Bio Technologies Basic Information List

Table 147. Lc-Bio Technologies Description and Business Overview

Table 148. Lc-Bio Technologies Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 149. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Lc-Bio Technologies (2021–2026)

Table 150. Lc-Bio Technologies Recent Developments

Table 151. CD Genomics Basic Information List

Table 152. CD Genomics Description and Business Overview

Table 153. CD Genomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 154. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of CD Genomics (2021–2026)

Table 155. CD Genomics Recent Developments

Table 156. Discovery Life Sciences Basic Information List

Table 157. Discovery Life Sciences Description and Business Overview

Table 158. Discovery Life Sciences Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 159. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Discovery Life Sciences (2021–2026)

Table 160. Discovery Life Sciences Recent Developments

Table 161. Applied Biomics Basic Information List

Table 162. Applied Biomics Description and Business Overview

Table 163. Applied Biomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 164. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Applied Biomics (2021–2026)

Table 165. Applied Biomics Recent Developments

Table 166. VProteomics Basic Information List

Table 167. VProteomics Description and Business Overview

Table 168. VProteomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 169. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of VProteomics (2021–2026)

Table 170. VProteomics Recent Developments

Table 171. Allumiqs Basic Information List

Table 172. Allumiqs Description and Business Overview

Table 173. Allumiqs Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 174. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Allumiqs (2021–2026)

Table 175. Allumiqs Recent Developments

Table 176. Westlake Omics Basic Information List

Table 177. Westlake Omics Description and Business Overview

Table 178. Westlake Omics Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 179. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Westlake Omics (2021–2026)

Table 180. Westlake Omics Recent Developments

Table 181. CDI Labs Basic Information List

Table 182. CDI Labs Description and Business Overview

Table 183. CDI Labs Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 184. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of CDI Labs (2021–2026)

Table 185. CDI Labs Recent Developments

Table 186. Proteome Sciences Basic Information List

Table 187. Proteome Sciences Description and Business Overview

Table 188. Proteome Sciences Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 189. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Proteome Sciences (2021–2026)

Table 190. Proteome Sciences Recent Developments

Table 191. Sapient Bioanalytics Basic Information List

Table 192. Sapient Bioanalytics Description and Business Overview

Table 193. Sapient Bioanalytics Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 194. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Sapient Bioanalytics (2021–2026)

Table 195. Sapient Bioanalytics Recent Developments

Table 196. Proteomics International Basic Information List

Table 197. Proteomics International Description and Business Overview

Table 198. Proteomics International Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 199. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Proteomics International (2021–2026)

Table 200. Proteomics International Recent Developments

Table 201. Cosmos Wisdom Basic Information List

Table 202. Cosmos Wisdom Description and Business Overview

Table 203. Cosmos Wisdom Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 204. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Cosmos Wisdom (2021–2026)

Table 205. Cosmos Wisdom Recent Developments

Table 206. MRM Proteomics Basic Information List

Table 207. MRM Proteomics Description and Business Overview

Table 208. MRM Proteomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 209. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of MRM Proteomics (2021–2026)

Table 210. MRM Proteomics Recent Developments

Table 211. Sinotech Genomics Basic Information List

Table 212. Sinotech Genomics Description and Business Overview

Table 213. Sinotech Genomics Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 214. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Sinotech Genomics (2021–2026)

Table 215. Sinotech Genomics Recent Developments

Table 216. Precision Biomarker Laboratories (PBL) Basic Information List

Table 217. Precision Biomarker Laboratories (PBL) Description and Business Overview

Table 218. Precision Biomarker Laboratories (PBL) Post-Translational Modification Proteomics Service Products, Services, and Solutions

Table 219. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Precision Biomarker Laboratories (PBL) (2021–2026)

Table 220. Precision Biomarker Laboratories (PBL) Recent Developments

Table 221. Revenue (US$ Million) in Post-Translational Modification Proteomics Service Business of Company 40 (2021–2026)

Table 222. Company 40 Recent Developments

Table 223. Key Raw Materials Lists

Table 224. Key Suppliers of Raw Materials Lists

Table 225. Post-Translational Modification Proteomics Service Downstream Customers

Table 226. Post-Translational Modification Proteomics Service Distributors List

Table 227. Research Programs/Design for This Report

Table 228. Key Data Information from Secondary Sources

Table 229. Key Data Information from Primary Sources

List of Figures

Figure 1. Post-Translational Modification Proteomics Service Product Picture

Figure 2. Global Post-Translational Modification Proteomics Service Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 4. Post-Translational Modification Proteomics Service Report Years Considered

Figure 5. Global Post-Translational Modification Proteomics Service Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Post-Translational Modification Proteomics Service Revenue in 2025

Figure 7. Post-Translational Modification Proteomics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Phosphorylation Picture

Figure 9. Acetylation Picture

Figure 10. Ubiquitination Picture

Figure 11. Methylation Picture

Figure 12. Glycosylation Picture

Figure 13. Lactylation Picture

Figure 14. Redox Picture

Figure 15. Palmitoylation Picture

Figure 16. Others Picture

Figure 17. Global Post-Translational Modification Proteomics Service Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Post-Translational Modification Proteomics Service Sales Value Market Share by Type, 2025 & 2032

Figure 19. Universities and Research Institutes Picture

Figure 20. Hospitals Picture

Figure 21. Pharmaceutical Companies Picture

Figure 22. Others Picture

Figure 23. Global Post-Translational Modification Proteomics Service Sales Value by End User (US$ Million), 2021 vs 2025 vs 2032

Figure 24. Global Post-Translational Modification Proteomics Service Sales Value Market Share by End User, 2025 & 2032

Figure 25. Oncology Picture

Figure 26. Cardiovascular Picture

Figure 27. Agriculture Picture

Figure 28. Neuroscience Picture

Figure 29. Other Picture

Figure 30. Global Post-Translational Modification Proteomics Service Sales Value by Research Areas (US$ Million), 2021 vs 2025 vs 2032

Figure 31. Global Post-Translational Modification Proteomics Service Sales Value Market Share by Research Areas, 2025 & 2032

Figure 32. Product Picture of Clinical Diagnostics

Figure 33. Product Picture of Drug Discovery

Figure 34. Product Picture of Others

Figure 35. Global Post-Translational Modification Proteomics Service Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 36. Global Post-Translational Modification Proteomics Service Sales Value Market Share by Application, 2025 & 2032

Figure 37. North America Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 38. North America Post-Translational Modification Proteomics Service Sales Value by Country (%), 2025 vs 2032

Figure 39. Europe Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 40. Europe Post-Translational Modification Proteomics Service Sales Value by Country (%), 2025 vs 2032

Figure 41. Asia Pacific Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 42. Asia Pacific Post-Translational Modification Proteomics Service Sales Value by Subregion (%), 2025 vs 2032

Figure 43. South America Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 44. South America Post-Translational Modification Proteomics Service Sales Value by Country (%), 2025 vs 2032

Figure 45. Middle East & Africa Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 46. Middle East & Africa Post-Translational Modification Proteomics Service Sales Value by Country (%), 2025 vs 2032

Figure 47. Key Countries/Regions Post-Translational Modification Proteomics Service Sales Value (%), 2021–2032

Figure 48. United States Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 49. United States Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 50. United States Post-Translational Modification Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 51. Europe Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 52. Europe Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 53. Europe Post-Translational Modification Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 54. China Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 55. China Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 56. China Post-Translational Modification Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 57. Japan Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 58. Japan Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 59. Japan Post-Translational Modification Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 60. South Korea Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 61. South Korea Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 62. South Korea Post-Translational Modification Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 63. Southeast Asia Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 64. Southeast Asia Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 65. Southeast Asia Post-Translational Modification Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 66. India Post-Translational Modification Proteomics Service Sales Value (US$ Million), 2021–2032

Figure 67. India Post-Translational Modification Proteomics Service Sales Value by Type (%), 2025 vs 2032

Figure 68. India Post-Translational Modification Proteomics Service Sales Value by Application (%), 2025 vs 2032

Figure 69. Post-Translational Modification Proteomics Service Value Chain

Figure 70. Post-Translational Modification Proteomics Service Cost Structure

Figure 71. Channels of Distribution (Direct Sales, and Distribution)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Post-Translational Modification Proteomics Service in 2026? zhanKai

The global market size of Post-Translational Modification Proteomics Service in 2026 was 827 Million USD.

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Post-Translational Modification Proteomics Service market size from 2026 to 2032? shouQi

Which companies rank high in the global Post-Translational Modification Proteomics Service market? shouQi

What was the global market size of Post-Translational Modification Proteomics Service in 2032? shouQi

Related Reports

Global Post-Translational Modification Proteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Post-Translational Modification Proteomics Service market is projected to grow from US$ 768 million in 2025 to US$ 1485 million by 2032, at a CAGR of 10.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-17
Pages: 215
USD 4900.00
(Single User License)
Global Post-Translational Modification Proteomics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Post-Translational Modification Proteomics Service market size was US$ 768 million in 2025 and is forecast to reach a readjusted size of US$ 1485 million by 2032 with a CAGR of 10.3% during the forecast period 2026-2032.
Published Date: 2026-07-17
Pages: 197
USD 4250.00
(Single User License)
Global Post-Translational Modification Proteomics Service Market Research Report 2026
The global Post-Translational Modification Proteomics Service market was valued at US$ 768 million in 2025 and is anticipated to reach US$ 1485 million by 2032, at a CAGR of 10.3% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 184
USD 2900.00
(Single User License)

Global Post-Translational Modification Proteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Post-Translational Modification Proteomics Service market is projected to grow from US$ 768 million in 2025 to US$ 1485 million by 2032, at a CAGR of 10.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-17
Pages: 215
USD 4900.00 (Single User License)
Global Post-Translational Modification Proteomics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Post-Translational Modification Proteomics Service market size was US$ 768 million in 2025 and is forecast to reach a readjusted size of US$ 1485 million by 2032 with a CAGR of 10.3% during the forecast period 2026-2032.
Published: 2026-07-17
Pages: 197
USD 4250.00 (Single User License)
Global Post-Translational Modification Proteomics Service Market Research Report 2026
The global Post-Translational Modification Proteomics Service market was valued at US$ 768 million in 2025 and is anticipated to reach US$ 1485 million by 2032, at a CAGR of 10.3% from 2026 to 2032.
Published: 2026-07-17
Pages: 184
USD 2900.00 (Single User License)